Journals / Türk Geriatri Dergisi / 2020 / Cilt: 23 - Sayı: 2

POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM

Pages
169–179
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Educating physicians as well as the public is essential to overcome polypharmacy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Polypharmacy has become a common health problem as populations age.
📊
Key Findings & Data:We aimed to determine the prevalence of chronic and cumulative polypharmacy in the geriatric population using primary healthcare services in Turkey.Materials and Methods: The electronic prescriptions ordered by family physicians across Turkey for geriatric patients (≥65 years) in the Prescription Information System during 2018 were studied.
💡
Conclusion & Impact:Educating physicians as well as the public is essential to overcome polypharmacy.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Introduction: Polypharmacy has become a common health problem as populations age. We aimed to determine the prevalence of chronic and cumulative polypharmacy in the geriatric population using primary healthcare services in Turkey.Materials and Methods: The electronic prescriptions ordered by family physicians across Turkey for geriatric patients (≥65 years) in the Prescription Information System during 2018 were studied. Chronic polypharmacy criteria were proportion of patients who were given prescriptions containing ≥5 drugs four or more times during a year. Cumulative polypharmacy was defined as proportion of patients who were prescribed ≥5 drugs with different ATC4 codes in a month or in each quarter of the year.Results: Turkey’s total population is 82 million; 7,186,204 are aged 65 and over, constituting 8.8% of the total. Of this geriatric population, 6,104,798 (85.0%) had at least one prescription in 2018. Each geriatric patient had 6.4 prescriptions, with each prescription containing an average of 2.9 drugs with different fourth-level Anatomical Therapeutic Chemical codes. Each drug was prescribed in 2.7 boxes on average. Of these prescribed patients, 14.3% received prescriptions containing ≥5 drugs four or more times during 2018. The percentage of patients who received at least one prescription per month containing ≥5 drugs ranged between 16.4% and 20.7%. The most commonly prescribed drugs were acetylsalicylic acid, diclofenac, paracetamol, and pantoprazole.Conclusion: Polypharmacy is a critical health problem among geriatric population in Turkey as in other industrialized countries. Educating physicians as well as the public is essential to overcome polypharmacy.

🔖

Cite This Article

AYDOS, T. R., AYDINGÖZ, S. E., LUX, K. M., EFE, O. E., İŞLI, F., AKSOY, M., KADI, E. (2020). POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi, Cilt: 23 - Sayı: 2, 169–179. https://ajindex.com/articles/398937

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Coskun Benlidayi I. Polypharmacy in geriatric rheumatology. Rheumatol Int 2019;39(6):1115-6. (PMID: 30810781)
  2. Bahat G, Tufan F, Akin S, Tufan A, Erten N, Karan MA: Rational drug use in the elderly. J Gerontol Geriat Res 2012;1:104. doi:10.4172/2167- 7182.1000104 3. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017;17(1):230. (PMID: 29017448)
  3. Pesante-Pinto JL. Clinical pharmacology and the risks of polypharmacy in the geriatric patient. Phys Med Rehabil Clin N Am 2017;28(4):739-46. (PMID: 29031340)
  4. Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of polypharmacy: methods. application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005;14(2):121-8. (PMID: 15386712)
  5. Carey IM, De Wilde S, Harris T, et al. What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 2008;25(8):693-706. (PMID: 18665661)
  6. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010;69(5):543-52. (PMID: 20573091)
  7. Grimmsmann T, Himmel W. Polypharmacy in primary care practices: an analysis using a large health insurance database. Pharmacoepidemiol Drug Saf 2009;18(12):1206-13. (PMID: 19795368)
  8. Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol 2018;10:289-98. (PMID: 29559811
  9. Wastesson JW, Morin L, Laroche ML, Johnell K. How chronic is polypharmacy in old age? A longitudinal nationwide cohort study. J Am Geriatr Soc 2019;67(3):455-62. (PMID: 30575952)
  10. Turkish Statistical Institute. Population by Years. Age Group and Sex. Census of Population—ABPRS. 2018. [Internet] Available from: http://www.turkstat.gov.tr/ UstMenu.do?metod=temelist. Accessed: 1.12.2019
  11. Aksoy M, Alkan A, İşli F. Rational drug use promotional activities of Ministry of Health. Turkiye Klinikleri J Pharmacol-Special Topics 2015;3(1):19-26
  12. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system. [Internet] Available from: https://www.who.int/classifications/atcddd/en/. Accessed: 1.12.2019
  13. Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC.